{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:04:49Z","timestamp":1789142689870,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:00:00Z","timestamp":1605225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:00:00Z","timestamp":1605225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004434","name":"Universit\u00e0 degli Studi di Firenze","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004434","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>SAPHO (synovitis, acne, pustolosis, hyperostosis and osteitis) syndrome is a rare autoinflammatory chronic disorder, presenting with non-infectious osteitis, sterile joint inflammation and skin manifestations including palmoplantar pustolosis and severe acne.<\/jats:p>\n                    <jats:p>It could be often misdiagnosed for its heterogeneous clinical presentation. Treatment is challenging and, due to the rarity of this syndrome, no randomized controlled clinical trials have been conducted. Empirical treatments, including non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, antibiotics and bisphosphonates and disease-modifying anti-rheumatic drugs (DMARDs) could be quite effective. Anti-tumor necrosis factor-alpha (anti-TNF-\u03b1) agents and interleukin-1 (IL-1) antagonists have shown promising results in refractory patients. Isotretinoin, commonly used for severe acne, has been rarely described as possible trigger of osteo-articular manifestations, in particular sacroiliitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>The case of a boy, affected by acne fulminans and depression, who presented with sacroiliitis after a 10-week treatment with isotretinoin is presented. After SAPHO diagnosis, NSAIDs therapy was started but the onset of bilateral gluteal hidradenitis suppurativa required the switch to a TNF-\u03b1 antagonist (Adalimumab) with the achievement of a good control of the disease. Despite specific therapy with sertraline, the patient continued to complains severe depression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our case reports a temporal association between the onset of osteo-articular symptoms and the introduction of isotretinoin, as previously described. However, this timeline is not sufficient to establish a causal role of this drug into the pathogenesis of sacroiliitis. At this regard, further studies are required. The occurrence of hidradenitis suppurativa during SAPHO course supported the introduction of TNF-\u03b1 blockers with a favourable result, as reported in a few cases in literature. The association between SAPHO syndrome and depressive mood disorders is already reported. Our patient experienced severe depression whose trend seems to be independent from the course of the main disease. Currently, it is not clarified if depression could be considered reactive to the underling disease or if it forms an integral part of the autoinflammatory disorder.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13052-020-00933-1","type":"journal-article","created":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T07:02:37Z","timestamp":1605250957000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["SAPHO syndrome: the supposed trigger by isotretinoin, the efficacy of adalimumab and the specter of depressive disorder: a case report"],"prefix":"10.1186","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1999-4389","authenticated-orcid":false,"given":"Michele","family":"Luzzati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Simonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Filippeschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Giani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Trapani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,13]]},"reference":[{"issue":"2","key":"933_CR1","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.rdc.2013.02.009","volume":"39","author":"S Carneiro","year":"2013","unstructured":"Carneiro S, Sampaio-Barros PD. SAPHO syndrome. Rheum Dis Clin North Am. 2013;39(2):401\u201318. .","journal-title":"Rheum Dis Clin North Am"},{"issue":"9","key":"933_CR2","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1007\/s10067-017-3751-1","volume":"36","author":"F Cianci","year":"2017","unstructured":"Cianci F, Zoli A, Gremese E, Ferraccioli G. Clinical heterogeneity of SAPHO syndrome: challenging diagnose and treatment. Clin Rheumatol. 2017;36(9):2151\u20138. .","journal-title":"Clin Rheumatol"},{"issue":"1","key":"933_CR3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13023-017-0658-5","volume":"12","author":"J Lu","year":"2017","unstructured":"Lu J, Duan Y, Zuo Z, et al. Depression in patients with SAPHO syndrome and its relationship with brain activity and connectivity. Orphanet J Rare Dis. 2017;12(1):103. .","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"933_CR4","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1080\/14397595.2017.1416733","volume":"28","author":"C Li","year":"2018","unstructured":"Li C, Cao Y, Zhang W. Clinical heterogeneity of SAPHO syndrome: Challenge of diagnosis. Mod Rheumatol. 2018;28(3):432\u20134. .","journal-title":"Mod Rheumatol"},{"issue":"Suppl","key":"933_CR5","doi-asserted-by":"publisher","first-page":"S106","DOI":"10.1016\/j.jinf.2016.04.030","volume":"72","author":"P Zimmermann","year":"2016","unstructured":"Zimmermann P, Curtis N. Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome - A challenging diagnosis not to be missed. J Infect. 2016;72(Suppl):S106-114. .","journal-title":"J Infect"},{"issue":"11","key":"933_CR6","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.3899\/jrheum.150013","volume":"42","author":"S Alkan","year":"2015","unstructured":"Alkan S, Kayiran N, Zengin O, et al. Isotretinoin-induced Spondyloarthropathy-related Symptoms: A Prospective Study. J Rheumatol. 2015;42(11):2106\u20139. .","journal-title":"J Rheumatol"},{"issue":"2","key":"933_CR7","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.jadohealth.2014.02.004","volume":"55","author":"S Freira","year":"2014","unstructured":"Freira S, Fonseca H, Ferreira PD, Vasconcelos P, Fonseca JE. SAPHO syndrome in an adolescent: a clinical case with unusual severe systemic impact. J Adolesc Health Off Publ Soc Adolesc Med. 2014;55(2):304\u20136. .","journal-title":"J Adolesc Health Off Publ Soc Adolesc Med"},{"issue":"1","key":"933_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2165\/11593250-000000000-00000","volume":"13","author":"S Garcovich","year":"2012","unstructured":"Garcovich S, Amelia R, Magarelli N, Valenza V, Amerio P. Long-term treatment of severe SAPHO syndrome with adalimumab: case report and a review of the literature. Am J Clin Dermatol. 2012;13(1):55\u20139. .","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"933_CR9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s10067-019-04675-2","volume":"39","author":"ASB Figueiredo","year":"2020","unstructured":"Figueiredo ASB, Oliveira AL, Caetano A, Moraes-Fontes MF. SAPHO: has the time come for tailored therapy? Clin Rheumatol. 2020;39(1):177\u201387. .","journal-title":"Clin Rheumatol"},{"issue":"6","key":"933_CR10","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1093\/rheumatology\/kew015","volume":"55","author":"C Li","year":"2016","unstructured":"Li C, Zuo Y, Wu N, et al. Synovitis, acne, pustulosis, hyperostosis and osteitis syndrome: a single centre study of a cohort of 164 patients. Rheumatology. 2016;55(6):1023\u201330. .","journal-title":"Rheumatology"},{"issue":"6 Suppl 1","key":"933_CR11","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1590\/abd1806-4841.20132500","volume":"88","author":"ASB Geller","year":"2013","unstructured":"Geller ASB, Alagia RFN. Sacroiliitis after use of oral isotretinoin\u2013association with acne fulminans or adverse effect? An Bras Dermatol. 2013;88(6 Suppl 1):193\u20136. .","journal-title":"An Bras Dermatol"},{"issue":"4","key":"933_CR12","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/j.1440-0960.2011.00841.x","volume":"53","author":"M Levinson","year":"2012","unstructured":"Levinson M, Gibson A, Stephenson G. Sacroiliitis secondary to isotretinoin: Sacroiliitis secondary to isotretinoin. Australas J Dermatol. 2012;53(4):298\u2013300. .","journal-title":"Australas J Dermatol"},{"issue":"12","key":"933_CR13","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1007\/s00296-019-04434-1","volume":"39","author":"BN Coskun","year":"2019","unstructured":"Coskun BN, Yagiz B, Pehlivan Y, Dalkilic E. Isotretinoin-induced sacroiliitis in patients with hidradenitis suppurativa: a case-based review. Rheumatol Int. 2019;39(12):2159\u201365. .","journal-title":"Rheumatol Int"},{"issue":"1","key":"933_CR14","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2741\/1817","volume":"11","author":"PS Burrage","year":"2006","unstructured":"Burrage PS. Matrix Metalloproteinases: Role In Arthritis. Front Biosci. 2006;11(1):529. .","journal-title":"Front Biosci"},{"issue":"12","key":"933_CR15","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1080\/10715760701717427","volume":"41","author":"RJS Dalmolin","year":"2007","unstructured":"Dalmolin RJS, Zanotto-filho A, De oliveira RB, Duarte RF, Pasquali MAB, Moreira JCF. Retinol and retinoic acid increase MMP-2 activity by different pathways in cultured Sertoli cells. Free Radic Res. 2007;41(12):1338\u201347. .","journal-title":"Free Radic Res"},{"issue":"1","key":"933_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jaad.2016.11.028","volume":"77","author":"T Greywal","year":"2017","unstructured":"Greywal T, Zaenglein AL, Baldwin HE, et al. Evidence-based recommendations for the management of acne fulminans and its variants. J Am Acad Dermatol. 2017;77(1):109\u201317. .","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"933_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/ijd.13740","volume":"57","author":"DA Vekic","year":"2018","unstructured":"Vekic DA, Woods J, Lin P, Cains GD. SAPHO syndrome associated with hidradenitis suppurativa and pyoderma gangrenosum successfully treated with adalimumab and methotrexate: a case report and review of the literature. Int J Dermatol. 2018;57(1):10\u20138. .","journal-title":"Int J Dermatol"},{"issue":"S6","key":"933_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/jdv.15849","volume":"33","author":"G Genovese","year":"2019","unstructured":"Genovese G, Caorsi R, Moltrasio C, Marzano AV. Successful treatment of co-existent SAPHO syndrome and hidradenitis suppurativa with adalimumab and methotrexate. J Eur Acad Dermatol Venereol. 2019;33(S6):40\u20131. .","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"933_CR19","doi-asserted-by":"crossref","unstructured":"Crowley EL, O\u2019Toole A, Gooderham MJ. Hidradenitis suppurativa with SAPHO syndrome maintained effectively with adalimumab, methotrexate, and intralesional corticosteroid injections. SAGE Open Med Case Rep 2018;6:2050313X1877872.","DOI":"10.1177\/2050313X18778723"},{"issue":"16","key":"933_CR20","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.2174\/1568026618666180516100805","volume":"18","author":"\u00d6 Varan","year":"2018","unstructured":"Varan \u00d6, Babao\u011flu H, G\u00f6ker B. Associations between Depressive Disorders and Inflammatory Rheumatic Diseases. Curr Top Med Chem. 2018;18(16):1395\u2013401. .","journal-title":"Curr Top Med Chem"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-020-00933-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13052-020-00933-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-020-00933-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T07:05:00Z","timestamp":1605251100000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-020-00933-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,13]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["933"],"URL":"https:\/\/doi.org\/10.1186\/s13052-020-00933-1","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,13]]},"assertion":[{"value":"26 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study has been approved by the institutional reviewed board of the Meyer Children Hospital.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of their clinical details and\/or clinical images was obtained from the parent of the patient. A copy of the consent form is available for review by the Editor of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"169"}}